NCT01438996View on ClinicalTrials.gov

Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Typhoid Fever
Interventions
BIOLOGICAL

NVGH Vi-CRM197

Vi-CRM197 glycoconjugated vaccine

Trial Locations (1)

2610

Centre for the Evaluation of Vaccination (CEV), Antwerp

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY